Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 3/20 | 0.51 |
| ▸ | GRIN3B | O60391 | 3/20 | 0.51 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.51 |
| ▸ | GRIN2A | Q12879 | 3/20 | 0.51 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.51 |
| ▸ | GRIN2C | Q14957 | 3/20 | 0.51 |
| ▸ | GRIN3A | Q8TCU5 | 3/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3921890 | 1.00 | GRIN2D (0.51) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Hydrochloric Acid SCHEMBL3924753 | 0.97 | GRIN2D (0.49) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Hydrochloric Acid SCHEMBL3924751 | 0.97 | GRIN2D (0.49) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL8085062 | 0.84 | MAPT (0.40) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL8085056 | 0.84 | MAPT (0.40) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL8094742 | 0.83 | ALDH1A1 (0.40) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL8094745 | 0.83 | ALDH1A1 (0.40) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL8083149 | 0.83 | MAPT (0.38) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL8083153 | 0.83 | MAPT (0.38) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL19887498 | 0.82 | GRIN2D (0.50) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019187831-A1 | METHOD FOR PRODUCING WAX ISOMERIZED OIL | ＪＸＴＧエネルギー株式会社 | 2019-10-03 | — | — | WO | disclosed |
| WO-2019189448-A1 | WAX ISOMERIZED OIL | ＪＸＴＧエネルギー株式会社 | 2019-10-03 | — | — | WO | disclosed |
| WO-2019189446-A1 | WAX ISOMERIZED OIL AND METHOD FOR PRODUCING SAME | ＪＸＴＧエネルギー株式会社 | 2019-10-03 | — | — | WO | disclosed |
| WO-2019187830-A1 | METHOD FOR PRODUCING WAX ISOMERIZED OIL | ＪＸＴＧエネルギー株式会社 | 2019-10-03 | — | — | WO | disclosed |
| US-20180051103-A1 | OLIGOMER PRODUCTION METHOD AND CATALYST | JXTG NIPPON OIL & ENERGY CORPORATION (JP) | 2018-02-22 | — | — | US | disclosed |
| US-20180051103-A1 | OLIGOMER PRODUCTION METHOD AND CATALYST | JXTG NIPPON OIL & ENERGY CORPORATION (JP) | 2018-02-22 | — | — | US | disclosed |
| EP-1919850-B1 | NITRO SUBSTITUTED ALPHA-OLEFIN SYNTHESIS CATALYSTS | DU PONT (US) | 2009-03-18 | — | — | EP | disclosed |
| US-20080194768-A1 | Nitro substituted alpha -olefin synthesis catalysts | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-08-14 | — | — | US | disclosed |
| US-20080194768-A1 | Nitro substituted alpha -olefin synthesis catalysts | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-08-14 | — | — | US | disclosed |
| EP-1919850-A2 | NITRO SUBSTITUTED ALPHA-OLEFIN SYNTHESIS CATALYSTS | E.I.Du pont de nemours and company (US) | 2008-05-14 | — | — | EP | disclosed |
| WO-2007021955-A2 | NITRO SUBSTITUTED α-OLEFIN SYNTHESIS CATALYSTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180051103-A1 | OLIGOMER PRODUCTION METHOD AND CATALYST | OR51E2, NOD2, MSMO1 | GRIN2D 1095/4885GRIN3B 953/4885GRIN1 1248/4885 |
| US-20080194768-A1 | Nitro substituted alpha -olefin synthesis catalysts | ETFA, CBR1, ETFB | GRIN2D 1219/4885GRIN3B 2066/4885GRIN1 1998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.